Gut bacteria and energy metabolism in health and IBD
Part of Digestive system clinical trials.
This study looks at how the bacteria living in your gut affect your body's energy use. It includes both healthy volunteers and people with inactive Crohn's disease or ulcerative colitis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old.
- Your body mass index (BMI) is between 17 and 25.
- You have regular bowel movements (at least every other day, up to 3 times a day).
- If you have Crohn's or colitis, you have been in remission (no active symptoms) for at least 6 months without steroids.
- If you are a woman able to have children, you must use effective birth control.
- You have not taken antibiotics or antifungals by mouth in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Crohn's disease or ulcerative colitis (and healthy volunteers) to understand what affects the disease's progression and complications. It looks at factors like your gut bacteria and immune treatments.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
This trial tests whether a special diet (called an exclusion diet) plus a nutritional supplement can change your gut bacteria and help control active Crohn's disease. It may be a good option if you have mild-to-moderate symptoms and want to try a food-based approach before stronger medications.
This study looks at how fecal microbiota transplantation (FMT) affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. diff infection. It aims to understand how the donor bacteria settle in the gut.
This study tests if a standardized fecal transplant is safe and helpful for adults with moderately to severely active Crohn's disease who are already on maintenance therapy. The goal is to see if this treatment can reduce inflammation in the digestive tract.
This study analyzes your gut bacteria to see if it can predict how well you will respond to Crohn's disease treatments. If you are having a colonoscopy for routine care, you may be eligible.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.